World's top Biotechnology & Medical Research stocks

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconEXASExact Sciences$10.35bnn/an/a
us flag iconQGENQiagen NV$9.85bn27.31n/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
hk flag icon9926AkesoHK$73.83bnn/an/a
us flag iconRGCRegencell Bioscience Holdings$8.92bnn/an/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconMEDPMedpace Holdings$8.52bn22.63n/a
us flag iconBPMCBlueprint Medicines$8.27bnn/an/a
us flag iconCERECerevel Therapeutics Holdings$8.19bnn/an/a
us flag iconRVMDRevolution Medicines$7.65bnn/an/a
us flag iconTECHBIO-TECHNE$7.63bn38.650.66%
us flag iconVRNAVerona Pharma$7.18bnn/an/a
us flag iconCRLCharles River Laboratories International$7.11bn39.15n/a
us flag iconRETAReata Pharmaceuticals$6.52bnn/an/a
us flag iconLEGNLegend Biotech$6.43bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$6.18bnn/an/a
tw flag icon6446PHARMAESSENTIATWD181.96bn46.40.2%
us flag iconIONSIonis Pharmaceuticals$5.62bnn/an/a
us flag iconNUVLNuvalent$5.60bnn/an/a
au flag iconTLXTelix PharmaceuticalsAU$8.56bn136.58n/a